Spot urine protein‐to‐creatinine ratio as a diagnostic test in pre‐eclampsia: A gold standard?

Angélique Berthet,Stéphanie Bartolo,Damien Subtil,Elodie Clouqueur,Charles Garabedian,Henri Azaïs
DOI: https://doi.org/10.1002/ijgo.13094
2020-02-03
Abstract:ObjectiveTo determine the diagnostic accuracy and optimal threshold of the spot protein‐to‐creatinine ratio (PCR) compared to the gold standard, 24‐hour proteinuria (24HP), in patients with suspected pre‐eclampsia. MethodsA prospective observational study was performed from June 2015 to May 2017 of patients hospitalized for suspected pre‐eclampsia in a tertiary care referral center. To compare the two diagnostic tests, a spot urine sample was obtained to perform the PCR before starting the collection of the 24HP. Only patients who had both tests were analyzed. ResultsIn total, 148 patients (216 samples) were included. The two tests were highly correlated (r=0.80, P<0.001). The receiver operating characteristic curve analysis and the area under the curve (AUC=0.92) highlighted the accuracy of PCR in diagnosing a significant proteinuria and thus pre‐eclampsia. The optimal cut‐off using the Liu method was 56.9 mg/mmol (sensitivity=79.3%, specificity=91.5%). ConclusionThe results suggest that PCR could replace 24HP when diagnosing proteinuria in pre‐eclampsia. Moreover, it is a simple test, easy to realize and standardize, and cheap with no need of systematic hospitalization. The best cut‐off should be chosen thinking about the risks for adverse maternal and/or fetal outcomes. The test may help to optimize medical care in pre‐eclampsia worldwide.
obstetrics & gynecology
What problem does this paper attempt to address?